Item request has been placed!
×
Item request cannot be made.
×
Processing Request
The adaptor protein Shc integrates growth factor and ECM signaling during postnatal angiogenesis.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Sweet DT;Sweet DT; Chen Z; Wiley DM; Bautch VL; Tzima E
- Source:
Blood [Blood] 2012 Feb 23; Vol. 119 (8), pp. 1946-55. Date of Electronic Publication: 2011 Nov 16.
- Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
- Language:
English
- Additional Information
- Source:
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
- Publication Information:
Publication: 2021- : [New York] : Elsevier
Original Publication: New York, Grune & Stratton [etc.]
- Subject Terms:
- Abstract:
Angiogenesis requires integration of cues from growth factors, extracellular matrix (ECM) proteins, and their receptors in endothelial cells. In the present study, we show that the adaptor protein Shc is required for angiogenesis in zebrafish, mice, and cell-culture models. Shc knockdown zebrafish embryos show defects in intersegmental vessel sprouting in the trunk. Shc flox/flox; Tie2-Cre mice display reduced angiogenesis in the retinal neovascularization model and in response to VEGF in the Matrigel plug assay in vivo. Functional studies reveal a model in which Shc is required for integrin-mediated spreading and migration specifically on fibronectin, as well as endothelial cell survival in response to VEGF. Mechanistically, Shc is required for activation of the Akt pathway downstream of both integrin and VEGF signaling, as well as for integration of signals from these 2 receptors when cells are grown on fibronectin. Therefore, we have identified a unique mechanism in which signals from 2 critical angiogenic signaling axes, integrins and VEGFR-2, converge at Shc to regulate postnatal angiogenesis.
- References:
EMBO J. 1999 Feb 15;18(4):882-92. (PMID: 10022831)
Immunol Rev. 2003 Feb;191:183-95. (PMID: 12614360)
Oncogene. 2001 Oct 1;20(44):6322-30. (PMID: 11607835)
Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1082-90. (PMID: 19801450)
Science. 1999 Aug 13;285(5430):1028-32. (PMID: 10446041)
Nature. 2005 Dec 15;438(7070):932-6. (PMID: 16355210)
Circulation. 2010 Jun 8;121(22):2407-18. (PMID: 20497976)
Dev Dyn. 1999 May;215(1):2-11. (PMID: 10340752)
Cell. 1996 Nov 15;87(4):733-43. (PMID: 8929541)
Science. 2007 Jul 13;317(5835):251-6. (PMID: 17626887)
Cell. 1994 Dec 30;79(7):1157-64. (PMID: 7528107)
J Cell Biol. 2003 Jun 23;161(6):1163-77. (PMID: 12810700)
Am J Pathol. 2000 Apr;156(4):1345-62. (PMID: 10751360)
Nat Med. 2002 Jan;8(1):27-34. (PMID: 11786903)
Hypertension. 2010 Jul;56(1):121-8. (PMID: 20516397)
Mol Cell Biol. 2001 Mar;21(5):1540-51. (PMID: 11238891)
Science. 1997 Dec 19;278(5346):2075-80. (PMID: 9405336)
Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10266-71. (PMID: 19509335)
Cell Cycle. 2009 Jan 15;8(2):231-5. (PMID: 19164921)
Development. 2007 Sep;134(18):3317-26. (PMID: 17720695)
Mol Cell Biol. 1999 Dec;19(12):8169-79. (PMID: 10567542)
J Cell Biol. 2008 Jul 14;182(1):185-96. (PMID: 18606845)
Cell. 1998 Nov 13;95(4):507-19. (PMID: 9827803)
Development. 2010 Jul;137(14):2439-49. (PMID: 20570943)
Semin Cancer Biol. 2009 Oct;19(5):318-28. (PMID: 19482089)
Cell. 2009 May 15;137(4):736-48. (PMID: 19450519)
EMBO J. 1997 Feb 17;16(4):706-16. (PMID: 9049300)
Nat Genet. 2003 Mar;33(3):401-6. (PMID: 12590264)
Dev Biol. 2001 Feb 15;230(2):230-42. (PMID: 11161575)
Nature. 2009 Jun 25;459(7250):1131-5. (PMID: 19440194)
Nature. 2007 Nov 8;450(7167):285-8. (PMID: 17994097)
Circ Res. 2011 Jan 21;108(2):184-93. (PMID: 21148430)
Circ Res. 2010 Mar 19;106(5):932-40. (PMID: 20110534)
Blood. 2010 Sep 9;116(10):1787-94. (PMID: 20516367)
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2150-6. (PMID: 17673702)
Curr Opin Hematol. 2010 May;17(3):245-51. (PMID: 20308893)
Nat Rev Genet. 2001 Jan;2(1):39-48. (PMID: 11253067)
Microvasc Res. 2003 Sep;66(2):102-12. (PMID: 12935768)
Science. 1994 Apr 22;264(5158):569-71. (PMID: 7512751)
Genes Dev. 2000 May 1;14(9):1132-45. (PMID: 10809671)
Cell. 1992 Jul 10;70(1):93-104. (PMID: 1623525)
Nat Med. 2003 Jun;9(6):669-76. (PMID: 12778165)
Circ Res. 2007 Sep 14;101(6):570-80. (PMID: 17641225)
Nat Immunol. 2002 Aug;3(8):749-55. (PMID: 12101399)
Dev Cell. 2009 Jan;16(1):70-82. (PMID: 19154719)
Cell Cycle. 2008 Jul 1;7(13):1936-43. (PMID: 18604176)
Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):617-22. (PMID: 11950700)
J Neurosci. 2006 Jul 26;26(30):7885-97. (PMID: 16870734)
Nature. 2010 Apr 22;464(7292):1196-200. (PMID: 20364122)
J Biol Chem. 1999 Jun 25;274(26):18393-400. (PMID: 10373445)
- Grant Information:
P30 CA016086 United States CA NCI NIH HHS; R01 HL043174 United States HL NHLBI NIH HHS; R01 HL088632 United States HL NHLBI NIH HHS; T32 GM007092 United States GM NIGMS NIH HHS; T32 HL069768 United States HL NHLBI NIH HHS; HL088632 United States HL NHLBI NIH HHS; R01 HL43174 United States HL NHLBI NIH HHS
- Accession Number:
0 (Fibronectins)
0 (Integrins)
0 (Intercellular Signaling Peptides and Proteins)
0 (Shc Signaling Adaptor Proteins)
0 (Vascular Endothelial Growth Factor A)
0 (Zebrafish Proteins)
EC 2.7.10.1 (Vascular Endothelial Growth Factor Receptor-2)
EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)
- Publication Date:
Date Created: 20111119 Date Completed: 20120521 Latest Revision: 20211021
- Publication Date:
20250114
- Accession Number:
PMC3293649
- Accession Number:
10.1182/blood-2011-10-384560
- Accession Number:
22096252
No Comments.